Skip to content
healthcare.dev

Guaifenesin 1200 mg

NDC 25000-041, Guaifenesin 1200 mg, tablet, from MARKSANS PHARMA LIMITED.

Product NDC
25000-041
Status
Listed
Labeler
MARKSANS PHARMA LIMITED
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA217780
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/25000-041 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GUAIFENESIN1200 mg/1

Pharmacologic classes

Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]

Package NDCNDC-11Package
25000-041-1225000004112500 TABLET in 1 BOTTLE (25000-041-12)
25000-041-34250000041342 BLISTER PACK in 1 CARTON (25000-041-34) / 14 TABLET in 1 BLISTER PACK
25000-041-75250000041752 BLISTER PACK in 1 CARTON (25000-041-75) / 6 TABLET in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 25000-041 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/25000-041 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 25000-041. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.